Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers.

Int J Oncol · 2014 · PMC4215587 · PMID 25201346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Both the clinical and molecular ERBB2 had as highly significant hits the activated ERBB2 and MEK1 signatures (FDR q-value ≤0.01 for both).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.